Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL260P is a processed pseudogene that resembles the 7SL RNA, a non-coding RNA component of the signal recognition particle (SRP) complex responsible for directing newly synthesized secretory and membrane proteins to the endoplasmic reticulum; however, RN7SL260P itself is not functional and does not participate in SRP function or any known cellular regulatory pathway. Pseudogenes like RN7SL260P represent genomic traces of reverse-flow genetic events from functional RNAs but generally lack regulatory or coding activity in human cells.
None (not a drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 260, pseudogene (RN7SL260P).